Microchip Technology Earnings Call Signals Firm Recovery

Microchip Technology ((MCHP)) has held its Q3 earnings call. Read on for the main highlights of the call.

Microchip Technology Signals Robust Recovery Despite Lingering Headwinds

Microchip Technology’s latest earnings call painted a picture of a company firmly back in recovery mode, with demand strengthening, margins improving and guidance topping expectations. Management acknowledged meaningful near-term obstacles—high inventories, elevated leverage and ongoing manufacturing underutilization—but emphasized disciplined execution, improving end-markets and strong design-win momentum. For investors, the overall tone was constructive: the positives in revenue growth, profitability and backlog outweighed the balance-sheet and supply-chain challenges.

Revenue Growth and a Strong Guidance Beat

Net sales for the December quarter reached $1.186 billion, up 4% sequentially and 15.6% year over year, surpassing the high end of prior guidance. Management also delivered an upbeat outlook for the March quarter, guiding to $1.26 billion in net sales plus or minus $20 million, implying about 6.2% sequential growth and nearly 30% growth versus a year ago at the midpoint. The book-to-bill ratio in December was well above 1, and the company entered the March quarter with backlog materially higher than it had entering December, signaling continued strength in underlying demand and providing added visibility into near-term revenue.

Non-GAAP Margins Show Powerful Rebound

Profitability rebounded sharply on a non-GAAP basis. Gross margin expanded to 60.5%, up 379 basis points sequentially, while operating margin climbed to 28.5%, an improvement of 418 basis points quarter over quarter and 800 basis points year over year. Non-GAAP net income came in at $252.8 million, with diluted EPS of $0.44, beating the high end of original guidance by $0.04. For the March quarter, management guided non-GAAP EPS to a range of $0.48 to $0.52, underscoring confidence that higher volumes and better mix can offset persistent cost headwinds.

Healthy Cash Generation and Free Cash Flow

Microchip continued to generate solid cash, with $341.4 million in cash flow from operations and $305.6 million in adjusted free cash flow during the December quarter. Adjusted EBITDA reached $402 million, representing 33.9% of net sales, while trailing twelve-month adjusted EBITDA was $1.23 billion. This robust cash generation is central to the company’s strategy of deleveraging the balance sheet while still funding targeted growth investments and maintaining its dividend.

Inventory and Distribution Channels Moving Back Toward Normal

Inventory management showed signs of progress. Ending inventory fell to $1.058 billion, down $37.6 million sequentially, while distributor inventory stood at 28 days, considered within the company’s normal range. Importantly for investors watching channel health, the gap between sell-in and sell-through at distributors narrowed sharply—from $52.9 million in September to $11.7 million in December—indicating that the distribution channel is normalizing and previously elevated buffers are being worked down.

Design Wins Drive Momentum in Connectivity and Data Center

Microchip highlighted a series of important design wins underscoring its strategic positioning in connectivity and data center markets. The company announced a collaboration with Hyundai Motor Group centered on 10BASE-T1S automotive Ethernet, reinforcing its automotive networking credentials. In the data center space, Microchip secured three design wins for its Gen6 PCIe switches, including one expected to deliver more than $100 million in revenue in calendar 2027. Management also cited leadership claims for its 3nm Gen6 PCIe solutions, which are sampling with hyperscale customers, and pointed to strong momentum in automotive and industrial Ethernet technologies, such as T1S and ASA, as key growth engines.

CapEx Discipline and a Clear Deleveraging Path

The company is exercising tight operational discipline on capital spending while charting a clearer path to lower leverage. Capital expenditures were just $22.5 million in the December quarter, and Microchip expects fiscal 2026 capex at or below $100 million, a relatively light investment level for a company of its scale. Net debt to adjusted EBITDA improved to 4.18 times from 4.69 times sequentially, reflecting incremental progress on deleveraging. Management reiterated that excess free cash flow, after funding dividends, will be directed toward paying down debt, and share buybacks will remain on hold until leverage declines materially.

Demand Recovery Broadens Across End Markets

End-market commentary was notably more upbeat. Management reported a broadening demand recovery spanning automotive, industrial, communications, data center, aerospace and defense, and even consumer markets. The strongest performance came from aerospace and defense, as well as networking and data center solutions, where secular demand for connectivity and high-speed data infrastructure remains robust. This broad-based recovery lessens dependence on any single vertical and provides a more diversified growth runway.

Improving Factory Outlook and Longer-Term Margin Ambitions

Microchip expects its margin profile to remain healthy and to improve over time despite residual headwinds. For the March quarter, the company guided non-GAAP gross margins to 60.5% to 61.5%, essentially sustaining the recent step-up. Management reiterated a long-term gross margin target around 65%, citing favorable product mix—particularly higher-margin, foundry-produced products—and a gradual ramp of internal fabs as key drivers. As factory utilization improves and product mix shifts toward more profitable lines, the company expects these structural factors to support further margin expansion over the longer term.

Inventory Reserves and Underutilization Still a Drag

Behind the robust non-GAAP margin improvements, the company is still absorbing substantial charges tied to inventory and underutilized capacity. In December, Microchip booked $58.4 million in new inventory reserves and $51.7 million in capacity underutilization charges on a non-GAAP basis. Management cautioned that underutilization charges will persist and could take years to fully normalize, representing a multi-quarter headwind to gross margins as internal fabs gradually ramp back to higher loading levels.

GAAP Earnings Lag Due to Significant Adjustments

While non-GAAP metrics showed strong profitability, GAAP results remained subdued due to sizable non-cash and special items. GAAP operating expenses included $107.6 million of amortization of acquisition-related intangibles, $62.1 million of share-based compensation, and $4.8 million of special charges, largely associated with the closure of Fab 2. As a result, GAAP net income attributable to common shareholders was only $34.9 million, or $0.06 per share—far below non-GAAP earnings. For investors, this gap underscores the importance of understanding the adjustment items when assessing the underlying earnings power.

Elevated Inventory Days Pose Ongoing Risk

Despite sequential improvements in absolute dollar terms, overall inventory levels remain high. Total inventory at quarter end represented 201 days of supply. Notably, about 17 days of this inventory is tied to long life-cycle, high-margin products whose manufacturing capacity has been end-of-lifed by supply partners. While these products can be attractive from a margin standpoint, supply uncertainty around these legacy lines could create risks for future margin sustainability and customer fulfillment if alternative capacity or sourcing arrangements are not secured in time.

Leverage Still High, Keeping Capital Returns Constrained

Even with improving trends, Microchip’s leverage remains elevated and continues to shape capital allocation decisions. Management acknowledged that net debt to adjusted EBITDA, at 4.18 times, is still higher than desired and stressed that prior-cycle volatility has made the company more cautious. Reducing leverage is a clear priority, with management committed to using excess free cash flow after dividends to pay down debt. Share repurchases will stay paused until leverage falls to more comfortable levels, limiting near-term optionality for enhanced shareholder returns but improving long-term balance-sheet resilience.

Supply-Chain and Foundry Constraints Tighten

The supply backdrop is becoming more challenging in selected areas. Management reported growing constraints on certain substrates, subcontractor capacity, and advanced-node foundry supply. Lead times have begun to stretch on some products, and customer expedite requests have risen meaningfully. These bottlenecks could temporarily limit Microchip’s ability to fully capitalize on strengthening demand and may also complicate efforts to steadily expand margins, particularly if the company is forced to navigate component shortages or pay premiums for constrained capacity.

Lumpy Licensing and “Other” Revenue

December results were helped by a notable boost from “other” revenue streams, including licenses, FPGA, memory and timing products. This category benefited from one-time licensing-related items that management does not expect to repeat fully in the March quarter. As a result, investors should expect some lumpiness in quarter-to-quarter revenue and gross margin comparisons, especially as these higher-margin, less predictable contributions swing up or down relative to core product sales.

Guidance and Outlook: Strong Momentum with Measured Caution

Looking ahead, Microchip guided March quarter net sales to $1.26 billion plus or minus $20 million, implying mid-single-digit sequential growth and nearly 30% year-over-year growth at the midpoint. Non-GAAP gross margin is expected to remain strong at 60.5% to 61.5%, with operating profit projected at 28.8% to 30.2% of sales and non-GAAP EPS in the $0.48 to $0.52 range. The company anticipates a non-GAAP cash tax rate of about 10% and capital expenditures at or below $100 million in fiscal 2026, underscoring its capex-light stance. Management plans to deploy adjusted free cash flow—$305.6 million in December—with a clear focus on reducing debt after paying dividends, gradually lowering net debt from current levels (net debt/adjusted EBITDA of 4.18, on trailing EBITDA of $1.23 billion). Inventory reserves are expected to largely normalize by March, although capacity underutilization charges, $51.7 million in December, will only decline modestly as fabs ramp over a multi-year horizon.

In sum, Microchip Technology’s earnings call outlined a business regaining its footing, with strong revenue growth, improving margins, solid cash generation and healthy design-win momentum across attractive end markets. Investors still need to weigh elevated leverage, high inventory days and ongoing underutilization and supply-chain constraints, but management’s disciplined capital spending and focus on deleveraging offer a framework for de-risking the story over time. If the company can sustain demand strength while gradually working down these structural headwinds, the setup from this quarter’s results and guidance appears favorable for long-term shareholders.